These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21288118)

  • 1. The use of Pro Re Nata or Statim medications for behavioral control: a summary of experience at a tertiary care children's mental health center.
    Swart GT; Siman E; Stewart SL
    J Child Adolesc Psychopharmacol; 2011 Feb; 21(1):67-77. PubMed ID: 21288118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of pro re nata medications in acute inpatient care.
    Stein-Parbury J; Reid K; Smith N; Mouhanna D; Lamont F
    Aust N Z J Psychiatry; 2008 Apr; 42(4):283-92. PubMed ID: 18330770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro re nata medication for psychoses: an audit of practice in two metropolitan hospitals.
    Geffen J; Sorensen L; Stokes J; Cameron A; Roberts MS; Geffen L
    Aust N Z J Psychiatry; 2002 Oct; 36(5):649-56. PubMed ID: 12225449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services.
    Paton C; Flynn A; Shingleton-Smith A; McIntyre S; Bhaumik S; Rasmussen J; Hardy S; Barnes T
    J Intellect Disabil Res; 2011 Jul; 55(7):665-74. PubMed ID: 21507097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to changing practice from pro re nata prescriptions to patient group directions in acute mental health settings.
    Price O; Baker JA
    J Psychiatr Ment Health Nurs; 2013 Sep; 20(7):623-30. PubMed ID: 22957970
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Saito E; Eng S; Grosso C; Ozinci Z; Van Meter A
    J Child Adolesc Psychopharmacol; 2020 May; 30(4):250-260. PubMed ID: 31800304
    [No Abstract]   [Full Text] [Related]  

  • 7. Changing utilization of pro re nata ('as needed') sedation in a child and adolescent psychiatric inpatient unit.
    Dean AJ; Scott J; McDermott BM
    Aust N Z J Psychiatry; 2009 Apr; 43(4):360-5. PubMed ID: 19296292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of evidence that the pro re nata regimen confers benefit: a review of the studies.
    Yoshida K; Suzuki T; Uchida H; Mimura M
    Int Clin Psychopharmacol; 2013 Sep; 28(5):228-37. PubMed ID: 23727905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of surveillance data in developing geographic dissemination strategies: a study of the diffusion of olanzapine to Michigan children insured by medicaid.
    Penfold RB; Kelleher KJ
    Clin Ther; 2007 Feb; 29(2):359-70; discussion 358. PubMed ID: 17472829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro Re Nata (PRN) prescription in an Inpatient Low Secure Learning Disability Unit.
    Thalitaya MD; Tirumalaraju V; Thyagarajan S; Reddy N; Raju S; Iqbal M
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S473-6. PubMed ID: 26417820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro re nata medication for psychoses: the knowledge and beliefs of doctors and nurses.
    Geffen J; Cameron A; Sorensen L; Stokes J; Roberts MS; Geffen L
    Aust N Z J Psychiatry; 2002 Oct; 36(5):642-8. PubMed ID: 12225448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice.
    Paton C; Bhatti S; Purandare K; Roy A; Barnes T
    BMJ Open; 2016 Dec; 6(12):e013116. PubMed ID: 27920085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Psychotropic PRN Medications in a Canadian Psychiatric Intensive Care Unit.
    Casol M; Tong A; Ng JCY; McGloin R
    J Am Psychiatr Nurses Assoc; 2023; 29(2):103-111. PubMed ID: 34109871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological concerns in a trial of ziprasidone and olanzapine.
    Carnahan RM; Perry PJ
    Am J Psychiatry; 2005 Jul; 162(7):1391; author reply 1391-2. PubMed ID: 15994736
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of the prescription and administration of sedative PRN medication to older adults at a secure hospital.
    Haw C; Wolstencroft L
    Int Psychogeriatr; 2014 Jun; 26(6):943-51. PubMed ID: 24565334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Young People With Antipsychotic Medications in the United States.
    Olfson M; King M; Schoenbaum M
    JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Administration of
    Jimu M; Doyle L
    Issues Ment Health Nurs; 2019 Jun; 40(6):511-517. PubMed ID: 30917088
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychopharmacology and mental retardation: a 10 year review (1990-1999).
    Matson JL; Bamburg JW; Mayville EA; Pinkston J; Bielecki J; Kuhn D; Smalls Y; Logan JR
    Res Dev Disabil; 2000; 21(4):263-96. PubMed ID: 10983783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administered antipsychotic pro re nata medications in psychiatric inpatients. Pre- and post-accreditation comparison.
    Al-Sughayir MA
    Saudi Med J; 2014 Feb; 35(2):172-7. PubMed ID: 24562517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro re nata medication for psychiatric inpatients: time to act.
    Hilton MF; Whiteford HA
    Aust N Z J Psychiatry; 2008 Jul; 42(7):555-64. PubMed ID: 18612858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.